Immunological studies in acute myeloid leukaemia: PHA responsiveness and serum inhibitory factors.
D046508:Culture Techniques; D003520:Cyclophosphamide / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003857:Deoxyuridine / Q000378:metabolism; D006801:Humans; D007106:Immune Sera; D007111:Immunity, Cellular; D007456:Iodine Isotopes; D037102:Lectins; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000276:immunology*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000378:metabolism; D013866:Thioguanine / Q000627:therapeutic use
D004273:DNA, Neoplasm; D007106:Immune Sera; D007456:Iodine Isotopes; D037102:Lectins; D003520:Cyclophosphamide; D013866:Thioguanine; D003857:Deoxyuridine